ArticleToxics2026
Antimicrobial Peptide Sublancin Skin Sensitization and Irritation Assessment in Guinea Pigs and Rabbits.
Article in Toxics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study evaluated the skin sensitization of the antimicrobial peptide sublancin to support its safety assessment for topical application. Sensitization was assessed using the guinea pig maximization test (GPMT), in which animals received sublancin (2 mg/kg), vehicle (negative control), or 2,4-dinitrochlorobenzene (positive control) during induction and challenge phases. Skin reactions (erythema and edema) were recorded after challenge. Irritation was evaluated in rabbits following single and repeated applications of sublancin to intact and abraded skin, with observations made at multiple time points. In the GPMT, no erythema or edema was observed in the sublancin-treated group or negative control group at 24, 48, and 72 h post-challenge, corresponding to a sensitization rate of 0%. All animals in the positive control group exhibited moderate to severe erythema and edema (sensitization rate 100%). In both single- and repeated-dose rabbit irritation tests, sublancin induced no erythema or edema on intact or abraded skin at any observation point, resulting in a total irritation score of 0. Furthermore, no significant differences in the daily weight gain were observed between any experimental group and the negative group (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.